PCDHA5 is a calcium-dependent cell-adhesion molecule involved in establishing and maintaining neuronal connections in the brain 1. As a protocadherin family member, it functions in cell adhesion and is localized to the plasma membrane where it mediates cell-cell interactions critical for nervous system development 1. Mechanistically, PCDHA5 contributes to neuronal cell adhesion processes essential for proper brain circuit formation. Expression studies reveal that PCDHA5, along with related family members PCDHA2 and PCDHA3, is downregulated following viral infection and maternal immune activation in developing mouse brains 1. Diseases of relevance include schizophrenia, where PCDHA5 dysfunction may contribute to pathogenesis. Maternal immune activation during pregnancy downregulates schizophrenia-associated cell adhesion genes including PCDHA5 in fetal brains, linking genetic and environmental risk factors 1. Additionally, PCDHA5 has been identified as a differentially expressed gene associated with lung squamous cell carcinoma prognosis 2. Clinically, PCDHA5 may serve as a prognostic marker for lung cancer and represents a potential therapeutic target in neurodevelopmental and psychiatric disorders where neuronal connectivity is compromised. The gene's role in cell adhesion positions it as relevant for understanding both developmental and disease-related disruptions in neural circuitry.